Dr Linda Kahl
Dr. Linda Kahl is a dedicated and experienced advocate for biotechnology in the public interest. She is the Founder and Principal of SciScript Communications, a consulting firm serving research institutions, biotechnology companies, government agencies, and nonprofit organizations in the areas of biomarker discovery, genomics, molecular diagnostics, synthetic biology, and bioeconomics. Linda also maintains a law practice as Of Counsel with Perspectives Law Group and is a licensed patent attorney with bar admission to practice law in California and before the USPTO. She formerly served as Senior Counsel for the BioBricks Foundation, where she led development of the Open Material Transfer Agreement (OpenMTA), and as a member of the Committee for Safeguarding the Bioeconomy for the U.S. National Academies of Sciences, Engineering, and Medicine. Linda writes and lectures on topics relating to open science, and has been an invited speaker at numerous venues, including the European Science Open Forum, World Economic Forum, World Health Organization, and the U.S. National Academy of Sciences’ Committee on Science, Technology and Law.